rss
J Clin Pathol doi:10.1136/jcp.2006.041731

Basal-like breast cancer

  1. Leonard Da Silva (leonardd{at}qimr.edu.au)
  1. Molecular and Cellular Pathology, School of Medicine, The University of Queensland, Australia
    1. Catherine Clarke (catherine.clarke{at}qimr.edu.au)
    1. Molecular and Cellular Pathology, School of Medicine, The University of Queensland, Australia
      1. Sunil R Lakhani (s.lakhani{at}uq.edu.au)
      1. Molecular and Cellular Pathology, School of Medicine, The University of Queensland, Australia
        • Published Online First 11 May 2007

        Abstract

        "Basal" breast cancers are dominating the breast research literature at present and pathologists are under increasing pressure to evaluate for such a phenotype by their surgical and oncological colleagues. Yet, there is also much confusion about how to assess cancers, which immunohistochemical markers to use, what meaning and benefit this provides and what the surgeons and oncologists will do with the information. Much remains to be done to answer all these questions but here we try to shed light on some of the issues and suggest what is still to come.

        Register for free content


        Free trial
        Individuals may register for a free 60 day online trial to all content.

        Free archive
        The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

        Don't forget to sign up for content alerts so you keep up to date with all the articles as they ar